Charlotte Liisborg

Roskilde, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Impaired Vagal Tone Function-Based Regulation of Systemic Inflammation in Patients With Neovascular Age-Related Macular Degeneration.

Impaired Vagal Tone Function-Based Regulation of Systemic Inflammation in Patients With Neovascular Age-Related Macular Degeneration.

Journal: Investigative ophthalmology & visual science
Published: October 08, 2025

High Levels of C5a Are Associated With Reduced Macular Sensitivity in Patients With Myeloproliferative Neoplasms.

High Levels of C5a Are Associated With Reduced Macular Sensitivity in Patients With Myeloproliferative Neoplasms.

Journal: Investigative ophthalmology & visual science
Published: February 13, 2025

Interleukin-8 Promoter Polymorphism -251 A/T and Treatment Response in Neovascular Age-related Macular Degeneration.

Interleukin-8 Promoter Polymorphism -251 A/T and Treatment Response in Neovascular Age-related Macular Degeneration.

Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: November 09, 2023

Serum levels of IL-4, IL-13 and IL-33 in patients with age-related macular degeneration and myeloproliferative neoplasms.

Serum levels of IL-4, IL-13 and IL-33 in patients with age-related macular degeneration and myeloproliferative neoplasms.

Journal: Scientific reports
Published: November 04, 2022

Lower CXCR3 expression in both patients with neovascular AMD and advanced stages of chronic myeloproliferative blood cancers.

Lower CXCR3 expression in both patients with neovascular AMD and advanced stages of chronic myeloproliferative blood cancers.

Journal: PloS one
Published: April 15, 2022

Retinal drusen in patients with chronic myeloproliferative blood cancers are associated with an increased proportion of senescent T cells and signs of an aging immune system.

Retinal drusen in patients with chronic myeloproliferative blood cancers are associated with an increased proportion of senescent T cells and signs of an aging immune system.

Journal: Aging
Published: November 17, 2021

Patients with MPNs and retinal drusen show signs of complement system dysregulation and a high degree of chronic low-grade inflammation.

Patients with MPNs and retinal drusen show signs of complement system dysregulation and a high degree of chronic low-grade inflammation.

Journal: EClinicalMedicine
Published: September 22, 2021

Age-related macular degeneration and myeloproliferative neoplasms - A common pathway.

Age-related macular degeneration and myeloproliferative neoplasms - A common pathway.

Journal: Acta ophthalmologica
Published: August 22, 2021

Patients with myeloproliferative neoplasms and high levels of systemic inflammation develop age-related macular degeneration.

Patients with myeloproliferative neoplasms and high levels of systemic inflammation develop age-related macular degeneration.

Journal: EClinicalMedicine
Published: June 05, 2020

Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative Neoplasms.

Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative Neoplasms.

Journal: Cancers
Published: January 29, 2020

The transcriptome of peripheral blood mononuclear cells in patients with clinical subtypes of late age-related macular degeneration.

The transcriptome of peripheral blood mononuclear cells in patients with clinical subtypes of late age-related macular degeneration.

Journal: Immunity & ageing : I & A
Published: April 28, 2019
Showing 1-11 of 11

Last Updated: 09/26/2026